In this issue:- COVID-19 update
- Ozgene COVID-19 testing
- New access to animal data
With all the uncertainty of COVID-19, we hope you are safe and in good health. We are very fortunate here in Western Australia where the infection numbers are low and measures seem to be working to slow the spread. Our thoughts are with you in areas that have been heavily affected by COVID-19.
We want you to know that Ozgene is still here to meet your needs and we have put measures in place to mitigate the impact of the pandemic both in Australia and in the USA. Our laboratory and vivarium staff have implemented new cleaning and social distancing measures and all other staff are working from home. We have also prepared for potential supply issues by ordering additional consumables. At this stage work is still going ahead as planned and our timelines have not been impacted.
If your animal shipments are delayed due to COVID-19 and the mice are spending longer than expected in our facilities in Australia or in the USA, we would be happy to do further breeding, validation and phenotyping to reduce any delays to your research. Please contact us to discuss options.
Ozgene COVID-19 testing
CTMH Doctors Hospital in the Cayman Islands have approached Ozgene to retrofit their chemo compounding lab as a COVID-19 testing facility. Ozgene is sourcing equipment and providing organisational capability support and training to set up the testing. Watch the video to see Ozgene US President Joanne Deys and CEO Frank Koentgen explaining the plan for the testing.
New access to animal data
When all processes produce the desired result first time, the timeline can be as short as 18 weeks.
Our fastest KI & conditional KO projects took 20 weeks from vector construction to germline transmission.
The Simple Moving Average timeline of our recently completed gene targeting projects is 29 weeks.